| NCT04232228 |
A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn’s Disease by Patients and Health Care Providers |
https://ClinicalTrials.gov/show/NCT04232228 |
Recruiting |
Janssen-Cilag Ltd. |
2021-04-30 |
| NCT03942120 |
Post-Marketing Surveillance for Crohn’s Disease Participants Treated With Stelara (Ustekinumab) |
https://ClinicalTrials.gov/show/NCT03942120 |
Recruiting |
Janssen Korea, Ltd., Korea |
2021-11-30 |
| NCT03397108 |
Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03397108 |
Recruiting |
The Hospital for Sick Children |
2020-07-31 |
| NCT03366090 |
Immunological Profiles in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03366090 |
Recruiting |
Rijnstate Hospital |
2020-07-01 |
| NCT03871634 |
Assessment of Nutritional Status of Patients With Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03871634 |
Recruiting |
Harokopio University |
2020-12-31 |
| NCT03819257 |
Anorectal Function in Perianal Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03819257 |
Completed |
The Leeds Teaching Hospitals NHS Trust |
2020-02-22 |
| NCT03282903 |
The PRognostic Effect of Environmental Factors in Crohn’s and Colitis |
https://ClinicalTrials.gov/show/NCT03282903 |
Recruiting |
University of Edinburgh |
2020-10-31 |
| NCT03288961 |
Self Screening Tool for Crohn’s Perianal Fistula |
https://ClinicalTrials.gov/show/NCT03288961 |
Recruiting |
Kyungpook National University Hospital |
2019-12-01 |
| NCT03266471 |
Cytokines and Genes in Therapeutic Response in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03266471 |
Enrolling by invitation |
Vanderbilt University Medical Center |
2020-10-31 |
| NCT03262649 |
Manitoba Inflammatory Bowel Disease Cohort Study |
https://ClinicalTrials.gov/show/NCT03262649 |
Completed |
University of Manitoba |
2016-03-01 |
| NCT03223012 |
Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service |
https://ClinicalTrials.gov/show/NCT03223012 |
Completed |
AbbVie |
2019-02-28 |
| NCT03183661 |
A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial |
https://ClinicalTrials.gov/show/NCT03183661 |
Enrolling by invitation |
Anterogen Co., Ltd. |
2021-03-31 |
| NCT03143517 |
Fecal Calprotectin Collection Protocol |
https://ClinicalTrials.gov/show/NCT03143517 |
Completed |
DiaSorin Inc. |
2018-08-23 |
| NCT03096379 |
MRI Differentiating Gut TB and Crohn’s |
https://ClinicalTrials.gov/show/NCT03096379 |
Completed |
The University of Hong Kong |
2018-12-30 |
| NCT03090139 |
Sub-optimal Response to Anti-Tumor Necrosis Factor’s in Inflammatory Bowel Disease in Emerging Markets |
https://ClinicalTrials.gov/show/NCT03090139 |
Completed |
Takeda |
2018-06-13 |
| NCT03079700 |
Immune Modulation From Trichuris Suis |
https://ClinicalTrials.gov/show/NCT03079700 |
Completed |
University of Aarhus |
2012-12-31 |
| NCT03019016 |
Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right Colectomy |
https://ClinicalTrials.gov/show/NCT03019016 |
Completed |
Intuitive Surgical |
2017-09-30 |
| NCT02986724 |
A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD) |
https://ClinicalTrials.gov/show/NCT02986724 |
Active, not recruiting |
Takeda |
2020-08-31 |
| NCT02926300 |
Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn’s Disease(CD) |
https://ClinicalTrials.gov/show/NCT02926300 |
Recruiting |
Kang Stem Biotech Co., Ltd. |
2021-10-31 |
| NCT02899013 |
Description of Perianal Lesions in a Cohort of Crohn’s Disease Patients |
https://ClinicalTrials.gov/show/NCT02899013 |
Completed |
Groupe Hospitalier Paris Saint Joseph |
2016-12-31 |
| NCT02896985 |
Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn’s Disease Patients With Loss of Response ( PRADA ) |
https://ClinicalTrials.gov/show/NCT02896985 |
Completed |
AbbVie |
2020-03-11 |
| NCT02887287 |
Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02887287 |
Completed |
Sun Yat-sen University |
2015-10-31 |
| NCT02859675 |
Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02859675 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2023-07-31 |
| NCT02856763 |
Predictive Factors of ANTI-TNF Response in Luminal Crohn’s Disease Complicated by Abscess |
https://ClinicalTrials.gov/show/NCT02856763 |
Active, not recruiting |
Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives |
2019-01-31 |
| NCT02851134 |
Search for New Genetic Mutations Major Effect in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02851134 |
Completed |
University Hospital, Lille |
2018-04-30 |
| NCT02847884 |
IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study |
https://ClinicalTrials.gov/show/NCT02847884 |
Completed |
University of Alberta |
2017-12-31 |
| NCT02842450 |
Study of Photographs of Interest in Training to Obtain Good Reproducibility of the Diagnosis of Perianal Lesions of Crohn’s Disease Inspection in Internal Gastroenterology |
https://ClinicalTrials.gov/show/NCT02842450 |
Completed |
Groupe Hospitalier Paris Saint Joseph |
2017-05-31 |
| NCT02778464 |
Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02778464 |
Completed |
The Royal Wolverhampton Hospitals NHS Trust |
2020-01-31 |
| NCT02770599 |
Improving the Health Care in Inflammatory Bowel Disease. |
https://ClinicalTrials.gov/show/NCT02770599 |
Active, not recruiting |
University Hospital of North Norway |
2020-03-20 |
| NCT02760836 |
Predictive Model of Clinical Outcomes Using Web-based Self-reporting Symptom Diary for Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02760836 |
Recruiting |
Kyungpook National University Hospital |
2020-04-30 |
| NCT02750800 |
Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie’s Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) |
https://ClinicalTrials.gov/show/NCT02750800 |
Completed |
AbbVie |
2018-04-03 |
| NCT02745457 |
Body Composition in Children With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02745457 |
Active, not recruiting |
Schneider Children’s Medical Center, Israel |
2020-05-30 |
| NCT02735941 |
Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases |
https://ClinicalTrials.gov/show/NCT02735941 |
Completed |
Medical University of Graz |
2018-07-27 |
| NCT02727959 |
Inflammatory Bowel Disease in South Eastern Norway |
https://ClinicalTrials.gov/show/NCT02727959 |
Completed |
Oslo University Hospital |
2019-12-31 |
| NCT02709694 |
Imaging Biomarkers in Crohn’s Associated Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT02709694 |
Active, not recruiting |
Hospital for Special Surgery, New York |
2023-01-31 |
| NCT02707289 |
Retrospective Collection of PillCam SB Movies |
https://ClinicalTrials.gov/show/NCT02707289 |
Completed |
Medtronic - MITG |
2018-06-18 |
| NCT02674308 |
Entyvio (Vedolizumab) Long Term Safety Study |
https://ClinicalTrials.gov/show/NCT02674308 |
Active, not recruiting |
Takeda |
2021-07-22 |
| NCT02619552 |
Impact of Medical Treatment on Sexual Function in Patients With Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02619552 |
Completed |
University of Maryland, Baltimore |
2018-06-30 |
| NCT02678052 |
OTIS Vedolizumab Pregnancy Exposure Registry |
https://ClinicalTrials.gov/show/NCT02678052 |
Recruiting |
Takeda |
2022-11-30 |
| NCT03404557 |
Proteomic Analysis of Crohn’s Disease Macrophages in Response or Not to AIEC |
https://ClinicalTrials.gov/show/NCT03404557 |
Completed |
University Hospital, Clermont-Ferrand |
2019-01-18 |
| NCT02542917 |
Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study |
https://ClinicalTrials.gov/show/NCT02542917 |
Completed |
King’s College Hospital NHS Trust |
2016-07-31 |
| NCT02539368 |
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02539368 |
Completed |
Pfizer |
2018-10-31 |
| NCT02504255 |
Evaluation of Immunological Markers, Inflammatory and Clinical Relapse Psychological Predictive During Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02504255 |
Completed |
Hospices Civils de Lyon |
2014-04-30 |
| NCT02502552 |
Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort |
https://ClinicalTrials.gov/show/NCT02502552 |
Completed |
Centre Hospitalier Universitaire de Saint Etienne |
2015-10-31 |
| NCT02466217 |
Phenomics in Autoimmune and Inflammatory Diseases |
https://ClinicalTrials.gov/show/NCT02466217 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2022-07-31 |
| NCT02453607 |
The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02453607 |
Recruiting |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2019-06-30 |
| NCT02451839 |
An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY) |
https://ClinicalTrials.gov/show/NCT02451839 |
Completed |
AbbVie |
2017-12-05 |
| NCT02399683 |
Immune Modulation From Trichuris Trichiura |
https://ClinicalTrials.gov/show/NCT02399683 |
Completed |
University of Aarhus |
2012-12-31 |
| NCT02379117 |
Eating Behaviour in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02379117 |
Completed |
University of Nottingham |
2018-01-31 |
| NCT02322008 |
Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice |
https://ClinicalTrials.gov/show/NCT02322008 |
Completed |
Regionshospitalet Viborg, Skive |
2011-03-31 |
| NCT02316678 |
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics |
https://ClinicalTrials.gov/show/NCT02316678 |
Completed |
University of Pennsylvania |
2016-12-31 |
| NCT02274714 |
Dysmenorrhea in Women With Crohn’s Disease and Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02274714 |
Completed |
University of Wisconsin, Madison |
2017-01-31 |
| NCT02193048 |
Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02193048 |
Recruiting |
Ferring Pharmaceuticals |
2024-08-31 |
| NCT02161640 |
Vascular Dysfunction in Paediatric IBD |
https://ClinicalTrials.gov/show/NCT02161640 |
Completed |
Great Ormond Street Hospital for Children NHS Foundation Trust |
2016-11-30 |
| NCT02135289 |
The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID |
https://ClinicalTrials.gov/show/NCT02135289 |
Completed |
Chinese University of Hong Kong |
2019-07-31 |
| NCT02130362 |
A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn’s Disease (CD) |
https://ClinicalTrials.gov/show/NCT02130362 |
Active, not recruiting |
AbbVie |
2028-03-02 |
| NCT02108938 |
Brain-Gut Interactions in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02108938 |
Completed |
University of Wisconsin, Madison |
2015-05-18 |
| NCT02060318 |
Regulatory T-cells and Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT02060318 |
Completed |
Hvidovre University Hospital |
2016-03-07 |
| NCT01314079 |
Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn’s Fistula |
https://ClinicalTrials.gov/show/NCT01314079 |
Completed |
Anterogen Co., Ltd. |
2012-08-31 |
| NCT01298648 |
Special Investigation in Patients With Crohn’s Disease (All Patients Investigation) |
https://ClinicalTrials.gov/show/NCT01298648 |
Completed |
AbbVie |
2013-02-28 |
| NCT01297907 |
Bronchial Hyperreactivity in Children With Crohn Disease |
https://ClinicalTrials.gov/show/NCT01297907 |
Completed |
Rambam Health Care Campus |
2009-12-31 |
| NCT01289366 |
Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD) |
https://ClinicalTrials.gov/show/NCT01289366 |
Completed |
University of Erlangen-Nürnberg Medical School |
2011-08-31 |
| NCT02057016 |
Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02057016 |
Completed |
Catholic University of the Sacred Heart |
2014-12-31 |
| NCT02054533 |
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02054533 |
Completed |
Icahn School of Medicine at Mount Sinai |
2017-06-30 |
| NCT01966744 |
Self-Management Assistance for Recommended Treatment (SMART) Portal |
https://ClinicalTrials.gov/show/NCT01966744 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2016-06-30 |
| NCT01931644 |
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions |
https://ClinicalTrials.gov/show/NCT01931644 |
Recruiting |
Sanguine Biosciences |
2025-08-31 |
| NCT01916161 |
The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients |
https://ClinicalTrials.gov/show/NCT01916161 |
Completed |
National Health Service, United Kingdom |
2016-02-29 |
| NCT01891214 |
Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01891214 |
Completed |
Rennes University Hospital |
2016-04-30 |
| NCT01861288 |
Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT01861288 |
Completed |
Herlev Hospital |
2016-09-05 |
| NCT01860846 |
Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01860846 |
Completed |
AbbVie |
2016-02-29 |
| NCT01813500 |
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients |
https://ClinicalTrials.gov/show/NCT01813500 |
Completed |
Boston Medical Center |
2015-09-30 |
| NCT01797224 |
OTIS Autoimmune Diseases in Pregnancy Project |
https://ClinicalTrials.gov/show/NCT01797224 |
Recruiting |
University of California, San Diego |
2020-01-31 |
| NCT01793376 |
Development of Niv Score of Capsule Endoscopy in Patients With Crohn’s (CECDAIic) |
https://ClinicalTrials.gov/show/NCT01793376 |
Completed |
Medtronic - MITG |
2016-02-29 |
| NCT01768858 |
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01768858 |
Completed |
AbbVie |
2017-08-13 |
| NCT01759264 |
An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn’s Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR) |
https://ClinicalTrials.gov/show/NCT01759264 |
Completed |
AbbVie |
2014-05-31 |
| NCT01749813 |
Specific Carbohydrate Diet as Maintenance Therapy in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01749813 |
Completed |
Stanford University |
2015-05-31 |
| NCT01736046 |
Comparison of Standard and Low Dose CT Enterography for Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01736046 |
Completed |
University of British Columbia |
2015-01-31 |
| NCT01720368 |
OPERA Database - Crohn’s Protocol |
https://ClinicalTrials.gov/show/NCT01720368 |
Completed |
Dartmouth-Hitchcock Medical Center |
2015-03-31 |
| NCT01705522 |
Multimodal Approach in IBD Patients |
https://ClinicalTrials.gov/show/NCT01705522 |
Recruiting |
Clinical Hospital Colentina |
2019-09-30 |
| NCT01676324 |
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) |
https://ClinicalTrials.gov/show/NCT01676324 |
Completed |
University of British Columbia |
2013-03-31 |
| NCT01666626 |
Ultrasound Stiffness Imaging in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01666626 |
Completed |
University of Michigan |
2015-07-31 |
| NCT01573078 |
Psychology of Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01573078 |
Completed |
University of British Columbia |
2015-01-28 |
| NCT01555437 |
Assessment of Capsule Endoscopy Scoring Index (CESI), Harvey-Bradshaw Index (HBI) and Biological Markers in Small Bowel Crohn’s Disease (SBCD) |
https://ClinicalTrials.gov/show/NCT01555437 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2011-02-28 |
| NCT01545063 |
CAre of Patients With PArenteral Nutrition At Home |
https://ClinicalTrials.gov/show/NCT01545063 |
Completed |
KU Leuven |
2013-04-30 |
| NCT01517516 |
Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. |
https://ClinicalTrials.gov/show/NCT01517516 |
Completed |
University of California, Los Angeles |
2015-07-31 |
| NCT01476995 |
Prognostic Indicators as Provided by the EPIC ClearView |
https://ClinicalTrials.gov/show/NCT01476995 |
Completed |
Epic Research & Diagnostics, Inc. |
2011-06-30 |
| NCT01473927 |
Significance of Ficolin 2 in the Determination of Serological Activity in Chronic Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT01473927 |
Completed |
University of Bern |
2013-02-28 |
| NCT01468090 |
Disease Course in an IBD Cohort in the Era of Biological Treatment |
https://ClinicalTrials.gov/show/NCT01468090 |
Completed |
Hvidovre University Hospital |
2014-06-30 |
| NCT01464333 |
Special Investigation (Long-term Investigation) in Patients With Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01464333 |
Completed |
AbbVie |
2018-03-31 |
| NCT01428115 |
Reveal the Level of Anxiety in Patients With Crohn’s Disease Receiving Adalimumab |
https://ClinicalTrials.gov/show/NCT01428115 |
Completed |
AbbVie |
2013-10-31 |
| NCT01405105 |
Exacerbating Factors in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT01405105 |
Completed |
Dallas VA Medical Center |
2012-06-30 |
| NCT01392365 |
Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01392365 |
Completed |
Asan Medical Center |
2015-02-28 |
| NCT01365767 |
Contrast Ultrasound of the Small Intestine in Patients With Crohns Disease |
https://ClinicalTrials.gov/show/NCT01365767 |
Completed |
Regionshospitalet Silkeborg |
2011-09-30 |
| NCT01364896 |
Anal Human Papillomavirus in Inflammatory Bowel Disease Study |
https://ClinicalTrials.gov/show/NCT01364896 |
Completed |
University of Pittsburgh |
2014-01-31 |
| NCT01363427 |
Retrospective Data Analysis in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01363427 |
Completed |
Ferring Pharmaceuticals |
2010-05-31 |
| NCT01349920 |
Biomarkers of Intestinal Mucosal Healing in Crohn’s Disease (P08143) |
https://ClinicalTrials.gov/show/NCT01349920 |
Completed |
Merck Sharp & Dohme Corp. |
2015-09-28 |
| NCT01349504 |
Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT01349504 |
Completed |
Beth Israel Deaconess Medical Center |
2012-12-31 |
| NCT01331551 |
Mesalamine and Reproductive Health Study |
https://ClinicalTrials.gov/show/NCT01331551 |
Completed |
Harvard School of Public Health |
2018-08-31 |
| NCT04306939 |
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study |
https://ClinicalTrials.gov/show/NCT04306939 |
Recruiting |
University of Pittsburgh |
2025-12-01 |
| NCT04297566 |
MICISPORT Survey : Questionnaire |
https://ClinicalTrials.gov/show/NCT04297566 |
Active, not recruiting |
University Hospital, Montpellier |
2020-04-01 |
| NCT04272788 |
Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT04272788 |
Completed |
Second Affiliated Hospital of Wenzhou Medical University |
2019-09-29 |
| NCT04191707 |
Metabolomic Markers of Fatigue in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT04191707 |
Completed |
Corporacion Parc Tauli |
2019-12-01 |
| NCT04151420 |
Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment |
https://ClinicalTrials.gov/show/NCT04151420 |
Recruiting |
Maastricht University Medical Center |
2021-11-30 |
| NCT04135027 |
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn’s Disease Patients |
https://ClinicalTrials.gov/show/NCT04135027 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2020-12-31 |
| NCT04131504 |
Precision Crohn’s Disease Management Utilizing Predictive Protein Panels (ENvISION) |
https://ClinicalTrials.gov/show/NCT04131504 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2021-02-28 |
| NCT04119635 |
Pediatric Penetrating Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT04119635 |
Completed |
University Hospital, Montpellier |
2018-09-01 |
| NCT04113733 |
Combinatorial Single Cell Strategies for a Crohn’s Disease Gut Cell Atlas |
https://ClinicalTrials.gov/show/NCT04113733 |
Enrolling by invitation |
Vanderbilt University Medical Center |
2022-12-31 |
| NCT04088773 |
Biomarkers of Intestinal Fibrosis in Small Bowel Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT04088773 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2021-09-30 |
| NCT04079335 |
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD |
https://ClinicalTrials.gov/show/NCT04079335 |
Recruiting |
Chinese University of Hong Kong |
2021-01-28 |
| NCT04002180 |
Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn’s Disease] |
https://ClinicalTrials.gov/show/NCT04002180 |
Recruiting |
Takeda |
2023-10-31 |
| NCT03994224 |
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CD |
https://ClinicalTrials.gov/show/NCT03994224 |
Recruiting |
Chinese University of Hong Kong |
2021-02-18 |
| NCT03981939 |
Perianal Fistula (PAF) Validation and Burden of Illness Study |
https://ClinicalTrials.gov/show/NCT03981939 |
Completed |
Takeda |
2019-12-17 |
| NCT03964883 |
Infliximab Blood Test in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03964883 |
Completed |
Groupe Hospitalier Paris Saint Joseph |
2018-03-01 |
| NCT03952364 |
The PRECIOUS Study: Predicting Crohn’s & ColitIs Outcomes in the United States |
https://ClinicalTrials.gov/show/NCT03952364 |
Recruiting |
PredictImmune Ltd |
2021-06-30 |
| NCT03950726 |
Ileocolic Resection for Complex Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03950726 |
Completed |
University of Roma La Sapienza |
2017-12-31 |
| NCT03941184 |
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity |
https://ClinicalTrials.gov/show/NCT03941184 |
Recruiting |
Mayo Clinic |
2020-12-31 |
| NCT03939117 |
The IUSS Crohn’s Study: A Feasibility Study |
https://ClinicalTrials.gov/show/NCT03939117 |
Completed |
Portsmouth Hospitals NHS Trust |
2020-03-09 |
| NCT03915262 |
Exocrine Pancreatic Insufficiency’s Prevalence in Active Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03915262 |
Recruiting |
Hospices Civils de Lyon |
2020-12-02 |
| NCT03890445 |
Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease |
https://ClinicalTrials.gov/show/NCT03890445 |
Recruiting |
Sandoz |
2020-05-08 |
| NCT03884439 |
Infliximab Biosimilar “Pfizer” Drug Use Investigation (Crohn’s Disease or Ulcerative Colitis) |
https://ClinicalTrials.gov/show/NCT03884439 |
Recruiting |
Pfizer |
2023-03-13 |
| NCT03878498 |
Management of Anal Fistula of Crohn Disease |
https://ClinicalTrials.gov/show/NCT03878498 |
Active, not recruiting |
Rennes University Hospital |
2019-09-19 |
| NCT03846778 |
Risk Factors of Complications After Ileocolic Resection for Crohn Disease According to the Comprehensive Complication Index |
https://ClinicalTrials.gov/show/NCT03846778 |
Active, not recruiting |
University Hospital, Montpellier |
2020-03-01 |
| NCT03841045 |
Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases |
https://ClinicalTrials.gov/show/NCT03841045 |
Recruiting |
Soroka University Medical Center |
2020-12-31 |
| NCT03836612 |
Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03836612 |
Completed |
Momentum Data |
2019-09-01 |
| NCT03835780 |
The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study |
https://ClinicalTrials.gov/show/NCT03835780 |
Completed |
Momentum Data |
2019-08-01 |
| NCT03817983 |
MRE as a Screening Tool for axSpA in IBD |
https://ClinicalTrials.gov/show/NCT03817983 |
Recruiting |
Cambridge University Hospitals NHS Foundation Trust |
2020-02-08 |
| NCT03801928 |
Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03801928 |
Completed |
Pfizer |
2020-02-07 |
| NCT03776825 |
Permacol Paste in Perianal Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03776825 |
Recruiting |
Istituto Clinico Humanitas |
2019-10-01 |
| NCT03774485 |
Myoelectric GutPrint-Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03774485 |
Recruiting |
Stanford University |
2020-06-30 |
| NCT03757065 |
Cell Surface Marker Expression in Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT03757065 |
Enrolling by invitation |
Alpine Immune Sciences, Inc. |
2020-03-31 |
| NCT01218360 |
Observational Study of Disease Severity in Participants Diagnosed With Crohn’s Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn’s Disease (Protocol P06484) |
https://ClinicalTrials.gov/show/NCT01218360 |
Completed |
Merck Sharp & Dohme Corp. |
2015-01-31 |
| NCT03710486 |
A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn’s Disease (CD) Participants |
https://ClinicalTrials.gov/show/NCT03710486 |
Recruiting |
Takeda |
2021-09-30 |
| NCT03681652 |
Post-Operative Crohn’s Disease Outcome in Children |
https://ClinicalTrials.gov/show/NCT03681652 |
Recruiting |
Schneider Children’s Medical Center, Israel |
2022-12-31 |
| NCT03668249 |
A Study to Characterize Multidimensional Model to Predict the Course of Crohn’s Disease (CD) |
https://ClinicalTrials.gov/show/NCT03668249 |
Completed |
Takeda |
2019-09-16 |
| NCT03646708 |
Response Assessment in SB CD |
https://ClinicalTrials.gov/show/NCT03646708 |
Recruiting |
Washington University School of Medicine |
2023-05-30 |
| NCT03640637 |
The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases |
https://ClinicalTrials.gov/show/NCT03640637 |
Enrolling by invitation |
Odense University Hospital |
2020-12-31 |
| NCT03606499 |
Real-world Effectiveness of Ustekinumab in Participants Suffering From Crohn’s Disease With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases |
https://ClinicalTrials.gov/show/NCT03606499 |
Recruiting |
Janssen Cilag S.A.S. |
2021-04-30 |
| NCT03589183 |
Gut Microbiome in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03589183 |
Recruiting |
Kyunghee University Medical Center |
2028-03-31 |
| NCT03565432 |
Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel Diseases |
https://ClinicalTrials.gov/show/NCT03565432 |
Active, not recruiting |
Kyunghee University Medical Center |
2019-07-30 |
| NCT03553472 |
Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster |
https://ClinicalTrials.gov/show/NCT03553472 |
Completed |
University of Wisconsin, Madison |
2019-05-31 |
| NCT03532932 |
A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice |
https://ClinicalTrials.gov/show/NCT03532932 |
Recruiting |
Takeda |
2021-07-15 |
| NCT03496818 |
Effect of SB CD on Chylomicron |
https://ClinicalTrials.gov/show/NCT03496818 |
Recruiting |
Washington University School of Medicine |
2020-04-30 |
| NCT03495973 |
Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03495973 |
Active, not recruiting |
Janssen-Cilag Ltd. |
2020-09-30 |
| NCT03492944 |
Contrast Enhanced Ultrasound in Human Crohn’s Disease-Lumason |
https://ClinicalTrials.gov/show/NCT03492944 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2022-01-31 |
| NCT03488030 |
A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) |
https://ClinicalTrials.gov/show/NCT03488030 |
Completed |
Takeda |
2019-05-31 |
| NCT03481751 |
Validation and Interobserver Reliability of a Simple Ultrasound Score for Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03481751 |
Active, not recruiting |
Haukeland University Hospital |
2020-12-20 |
| NCT03477032 |
FMT in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03477032 |
Recruiting |
St Vincent’s Hospital Melbourne |
2019-12-31 |
| NCT03452501 |
Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients |
https://ClinicalTrials.gov/show/NCT03452501 |
Active, not recruiting |
Hikma Pharmaceuticals LLC |
2020-06-30 |
| NCT03439826 |
Junior / Senior Concordance in Ultrasound Assessment of Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03439826 |
Completed |
Rennes University Hospital |
2019-04-01 |
| NCT01241058 |
Registry of Pediatric Patients Diagnosed With Crohn’s Disease in Belgium |
https://ClinicalTrials.gov/show/NCT01241058 |
Completed |
Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition |
2015-04-30 |
| NCT01233310 |
Evaluation of Small Bowel Colon Capsule for Bowel Visualization in Crohn’s Disease Patients |
https://ClinicalTrials.gov/show/NCT01233310 |
Completed |
Medtronic - MITG |
2012-04-30 |
| NCT01183403 |
CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01183403 |
Completed |
Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives |
2012-07-31 |
| NCT01169207 |
Johns Hopkins Crohn’s Disease and Ulcerative Colitis Study |
https://ClinicalTrials.gov/show/NCT01169207 |
Active, not recruiting |
Johns Hopkins University |
2020-12-31 |
| NCT01140789 |
GWA Study in Patients With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT01140789 |
Recruiting |
Chinese University of Hong Kong |
2037-04-30 |
| NCT01105741 |
Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in Crohn’s Disease (CD) |
https://ClinicalTrials.gov/show/NCT01105741 |
Completed |
University of Calgary |
2013-04-30 |
| NCT01102855 |
Endomicroscopy and Crohn´s Disease |
https://ClinicalTrials.gov/show/NCT01102855 |
Completed |
University of Erlangen-Nürnberg Medical School |
2011-08-31 |
| NCT01099111 |
Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders |
https://ClinicalTrials.gov/show/NCT01099111 |
Completed |
King Fahad Medical City |
2012-01-31 |
| NCT01086059 |
OTIS Autoimmune Diseases in Pregnancy Project |
https://ClinicalTrials.gov/show/NCT01086059 |
Active, not recruiting |
University of California, San Diego |
2016-08-31 |
| NCT01083680 |
Effectiveness and Safety in Patients With Crohn´s Disease in Clinical Routine |
https://ClinicalTrials.gov/show/NCT01083680 |
Completed |
AbbVie |
2015-12-31 |
| NCT01083121 |
Surveillance of Humira Injection in Korean Patients |
https://ClinicalTrials.gov/show/NCT01083121 |
Completed |
AbbVie |
2012-06-30 |
| NCT01032525 |
Monroe County Inflammatory Bowel Disease (IBD) Registry |
https://ClinicalTrials.gov/show/NCT01032525 |
Completed |
University of Rochester |
2013-05-31 |
| NCT00988832 |
An Audit of Patients With Crohn’s Disease Treated With Infliximab (P06066) |
https://ClinicalTrials.gov/show/NCT00988832 |
Completed |
Merck Sharp & Dohme Corp. |
2010-12-31 |
| NCT00917514 |
An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen |
https://ClinicalTrials.gov/show/NCT00917514 |
Completed |
Medicpen AB |
2010-02-28 |
| NCT00844285 |
SECURE, the Cimzia ® Crohn’s Disease Post-Marketing Registry |
https://ClinicalTrials.gov/show/NCT00844285 |
Active, not recruiting |
UCB Pharma |
2025-08-31 |
| NCT04191395 |
Evolution and Treatments of Chronic Inflammatory Systemic Diseases |
https://ClinicalTrials.gov/show/NCT04191395 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2029-12-31 |
| NCT03340519 |
Early MRI Prediction of Crohns |
https://ClinicalTrials.gov/show/NCT03340519 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2020-10-31 |
| NCT03662919 |
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study |
https://ClinicalTrials.gov/show/NCT03662919 |
Recruiting |
Biogen |
2022-06-30 |
| NCT02580864 |
Bologna IBD Markers |
https://ClinicalTrials.gov/show/NCT02580864 |
Completed |
Nestlé |
2018-10-31 |
| NCT00816842 |
Plasma Citrulline Concentration in Tropical Enteropathy |
https://ClinicalTrials.gov/show/NCT00816842 |
Completed |
Azienda Ospedaliero-Universitaria di Parma |
2008-05-31 |
| NCT03913572 |
Treatment of Perianal Disease Using Adipose-derived Stem Cells |
https://ClinicalTrials.gov/show/NCT03913572 |
Recruiting |
University of California, San Diego |
2019-09-26 |
| NCT03285230 |
The French E3N Prospective Cohort Study |
https://ClinicalTrials.gov/show/NCT03285230 |
Active, not recruiting |
Institut National de la Santé Et de la Recherche Médicale, France |
1991-11-15 |
| NCT02839317 |
COmparison of MicroBiota AccordIng to Age in Crohn’s Disease (COMeBACk) |
https://ClinicalTrials.gov/show/NCT02839317 |
Recruiting |
University Hospital, Lille |
2021-05-31 |
| NCT02846961 |
Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02846961 |
Recruiting |
Kyungpook National University Hospital |
2018-09-30 |
| NCT02578238 |
Post-Marketing Surveillance of Humira in Korean Pediatric Crohn’s Disease (CD) Patients Under the “New-Drug Re-examination” |
https://ClinicalTrials.gov/show/NCT02578238 |
Completed |
AbbVie |
2017-05-31 |
| NCT04372108 |
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT04372108 |
Recruiting |
Janssen Scientific Affairs, LLC |
2029-08-31 |
| NCT02423512 |
The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness |
https://ClinicalTrials.gov/show/NCT02423512 |
Completed |
Icahn School of Medicine at Mount Sinai |
2017-06-13 |
| NCT01301417 |
Data Collection of Patients Treated With the ColonRingâ„¢ for the Creation of Circular Compression Anastomosis |
https://ClinicalTrials.gov/show/NCT01301417 |
Completed |
novoGI |
2011-08-31 |
| NCT04089514 |
A Real-world Study of Imraldi® Use |
https://ClinicalTrials.gov/show/NCT04089514 |
Recruiting |
Biogen |
2021-06-30 |
| NCT03897400 |
Ovarian Reserve in Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03897400 |
Completed |
Kanuni Sultan Suleyman Training and Research Hospital |
2019-09-01 |
| NCT00790543 |
Risk Stratification of Rapid Disease Progression in Children With Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT00790543 |
Active, not recruiting |
Emory University |
2019-12-31 |
| NCT00727298 |
Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) |
https://ClinicalTrials.gov/show/NCT00727298 |
Completed |
Merck Sharp & Dohme Corp. |
2011-08-31 |
| NCT00724958 |
Program Extension of Real Life Dosing of Remicade in Austria for Crohn’s Disease (Study P04052)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00724958 |
Completed |
Merck Sharp & Dohme Corp. |
2010-07-31 |
| NCT00724529 |
Post Marketing Surveillance of Remicade |
https://ClinicalTrials.gov/show/NCT00724529 |
Completed |
Janssen Korea, Ltd., Korea |
2011-08-31 |
| NCT00723905 |
Remicade Infusion Management Program |
https://ClinicalTrials.gov/show/NCT00723905 |
Completed |
Janssen Inc. |
2012-10-31 |
| NCT00723840 |
Assessment of the Social Cost of Crohn’s Disease: Economic and Quality of Life Aspects (Study P04560) |
https://ClinicalTrials.gov/show/NCT00723840 |
Completed |
Merck Sharp & Dohme Corp. |
2009-12-31 |
| NCT00711945 |
Growth Relapse and Outcomes With Therapy 1 |
https://ClinicalTrials.gov/show/NCT00711945 |
Completed |
European Society of Pediatric Gastroenterology, Hepatology and Nutrition |
2014-12-31 |
| NCT00705614 |
Postmarketing Safety Surveillance European Registry of Crohn’s Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035) |
https://ClinicalTrials.gov/show/NCT00705614 |
Completed |
Merck Sharp & Dohme Corp. |
2013-02-28 |
| NCT00676988 |
Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn’s Disease Patients |
https://ClinicalTrials.gov/show/NCT00676988 |
Completed |
University of Western Ontario, Canada |
2011-04-30 |
| NCT00606346 |
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT00606346 |
Active, not recruiting |
Janssen Biotech, Inc. |
2037-11-15 |
| NCT00587210 |
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel |
https://ClinicalTrials.gov/show/NCT00587210 |
Completed |
Mayo Clinic |
2008-12-31 |
| NCT00572780 |
Can CT Enteroclysis Predict the Outcome of Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT00572780 |
Completed |
Indiana University |
2012-01-31 |
| NCT00553176 |
The Crohn’s Therapy, Resource, Evaluation, and Assessment Tool Registry |
https://ClinicalTrials.gov/show/NCT00553176 |
Completed |
Janssen Biotech, Inc. |
2012-05-31 |
| NCT00524537 |
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn’s Disease (CD) |
https://ClinicalTrials.gov/show/NCT00524537 |
Completed |
AbbVie |
2015-12-31 |
| NCT00516776 |
The Innate Immune System and Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT00516776 |
Completed |
Norwegian University of Science and Technology |
2017-12-31 |
| NCT00492791 |
Endoscopic Severity Score of Small Bowel Crohn’s Disease With Wireless Capsule Endoscopy |
https://ClinicalTrials.gov/show/NCT00492791 |
Completed |
Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives |
2011-12-31 |
| NCT00468455 |
Post-Op Quality of Life After Colorectal Surgery |
https://ClinicalTrials.gov/show/NCT00468455 |
Completed |
University Hospitals Cleveland Medical Center |
2008-04-30 |
| NCT00440817 |
An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn’s Disease. |
https://ClinicalTrials.gov/show/NCT00440817 |
Completed |
Centocor Ortho Biotech Services, L.L.C. |
2006-08-31 |
| NCT00434551 |
MACCS: Multicenter Australian CE in Patients With Suspected Crohn’s Disease Study |
https://ClinicalTrials.gov/show/NCT00434551 |
Completed |
Medtronic - MITG |
2007-12-31 |
| NCT00289328 |
Glucocorticoid-induced Osteopenia in Children |
https://ClinicalTrials.gov/show/NCT00289328 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00261976 |
A Long-term Safety Study of Infliximab (Remicade) |
https://ClinicalTrials.gov/show/NCT00261976 |
Completed |
Centocor, Inc. |
2012-03-31 |
| NCT00237055 |
Infectious Agents in Pediatric Crohn’s |
https://ClinicalTrials.gov/show/NCT00237055 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00222378 |
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT00222378 |
Completed |
University of Miami |
2012-06-30 |
| NCT00215020 |
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT00215020 |
Completed |
Boston Children’s Hospital |
2006-06-30 |
| NCT00819663 |
Intestinal Wall Remodeling (Infliximab Therapy) in Crohn’s Disease Patients Undergoing Serial Computed Tomography (CT) Enterography |
https://ClinicalTrials.gov/show/NCT00819663 |
Completed |
Mayo Clinic |
2010-08-31 |
| NCT00138879 |
Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn’s Disease Patients |
https://ClinicalTrials.gov/show/NCT00138879 |
Completed |
St Mark’s Hospital Foundation |
NA |
| NCT00061737 |
Quality of Life in Pediatric Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT00061737 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00818272 |
Remicade Safety Line (Crohn’s Disease)(Study P03288)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00818272 |
Completed |
Merck Sharp & Dohme Corp. |
2010-12-31 |
| NCT00274209 |
Chromoendoscopy for Ulcerative Colitis Surveillance |
https://ClinicalTrials.gov/show/NCT00274209 |
Completed |
Indiana University |
2011-11-30 |